About NCTA2023-09-25T16:13:30+00:00

About NCTA

The National Cancer Treatment Alliance (NCTA) is a clinically integrated network (CIN) of leading oncology practices and pharmacies across the country.

The unique structure of a CIN allows NCTA practices to work together and directly with health plan sponsors to ensure patients receive high quality, patient-centered, and lower-cost cancer care. NCTA member practices are accountable for the care they provide and must prove their success through tracking and reporting of quality and value measures.

The NCTA is a for-profit benefit corporation subsidiary of the Community Oncology Alliance (COA), a national non-profit dedicated solely to independent, community oncology practices and, most importantly, the patients they serve. Through the NCTA, we are seeking to provide a solution to employers and health plan sponsors who are increasingly frustrated by an expensive, complex, and unfriendly cancer care system.

NCTA is also leveraging the expertise of its national oncology network to provide information, resources, and educational materials on key issues in cancer care to employers and employees, ranging from fundamental education on molecular and genetic testing; the importance and value of biosimilars; and understanding and assessing cancer care costs and quality.


Employers are the largest cancer care payer for people under the age of 65. For years, they have sought solutions that provide high-quality care, exceptional patient experience, and affordability. Yet it has become increasingly difficult to navigate cancer treatment, and health care costs continue to rise.

NCTA helps employers by contracting directly with them for cancer treatments so their employees have access to the highest-quality, locally accessible, and most affordable cancer care. NCTA’s national network of community oncology providers help employers and employees better understand key issues in cancer such as the value of diagnostic and genetic testing, the role of new immunotherapies, and the equivalency of biosimilars.

Frequently Asked Questions

Is NCTA up and running?2022-06-14T20:01:49+00:00

Yes, NCTA is fully functional and will continue to add more educational resources on key issues in cancer in the coming months. It has begun to build its Clinically Integrated Network (CIN), which will provide direct contracting for all oncology services and data driven informational studies to promote transparency around the cost of care.

Has NCTA engaged employers in the organization’s development?2022-06-14T20:02:18+00:00

The NCTA team has spoken with dozens of employers and health care purchasing organizations across the country. They have learned that there is a tremendous need for innovations that put employers and employees first: boosting quality and improve patients’ experience with cancer care and reducing costs.


Is NCTA membership open exclusively to members of COA?2022-06-14T20:02:50+00:00

No. NCTA membership is open to all high-performing oncology practices in the United States. Practices do not have to be a member of COA to join NCTA, but must be committed to delivering affordable, high-quality, and locally accessible cancer care to employers and their employees.

How can NCTA improve upon a broken drug benefits system dominated by large PBMs?2022-06-21T17:57:46+00:00

For decades, employers have utilized pharmacy benefit managers (PBMs) with little to show for it. NCTA’s Clinically Integrated Network will create transparency in drug benefit design and delivery where there currently is none and a first-rate treatment experience in patients.

Go to Top